secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2026-06-30T21:17:05+00:00
Accession:  0001193125-26-290823
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio closes $250M 0.75% convertible senior notes offering due 2032
--------------------------------------------------------------------------

- $250M aggregate principal of 0.75% Convertible Senior Notes due 2032; initial conversion price ~$7.84/share (35% premium).
- Net proceeds ~$241.2M; used to repay $58.5M loan, pay $14.9M for capped call, remainder for general corporate.
- Capped call transactions entered to reduce dilution; cap price $10.4580/share (80% premium).
- Underwriters' 30-day option for additional $37.5M notes.
- Prior loan agreement terminated upon full repayment of ~$58.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/0001193125-26-290823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/d81296d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-290823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer